{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:41:43Z","timestamp":1788536503129,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019652","name":"British University in Egypt","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>New, simple, accurate, sensitive and validated high performance thin layer chromatographic (HPTLC) method coupled with UV absorbance mode and fluorescence (FL) detectors which were used for simultaneous determination of ivabradine (IVA) and metoprolol (MET) in their bulk and pharmaceutical dosage form using TLC silica 60 F<jats:sub>254<\/jats:sub> plates and non-fluorescent TLC silica gel 60 plates. The developing system was chloroform: methanol: formic acid: ammonia (8.5:1.5:0.2:0.1, v\/v). Desnitometric analysis in UV absorbance mode was set at \u03bb\u2009=\u2009275\u00a0nm. While, fluorescence mode was performed with excitation at 260\u00a0nm for quantitative simultaneous determination of IVA and MET using optical filter K320. The retention factors values were 0.45\u2009\u00b1\u20090.05 and 0.89\u2009\u00b1\u20090.01 of IVA and MET, respectively. UV absorbance mode, linearity was 50.0\u2013600.0\u00a0ng\/band for IVA and 50.0\u2013900.0\u00a0ng\/band for MET. For fluorescence mode, the linearity ranges were 18.0\u2013400.0\u00a0ng\/band and 50.0\u2013550.0\u00a0ng\/band for IVA and MET; respectively. ICH guidelines were followed in respect to linearity and range, accuracy, precision and selectivity, limit of detection (LOD), limit of quantitation (LOQ) and robustness. The analytical eco-scale, green analytical procedure index (GAPI) and analytical greenness metric tools were used to assess the suggested method. The quantitative proposed method results showed there was no statistically significant difference at 95% confidence when compared to the reported method of high performance liquid chromatography (HPLC).<\/jats:p>","DOI":"10.1186\/s13065-023-01025-x","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:22:47Z","timestamp":1694701367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative HPTLC study for simultaneous determination of ivabradine and metoprolol using UV and fluorescence detectors"],"prefix":"10.1186","volume":"17","author":[{"given":"M.","family":"Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Mowaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abou El-Alamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"1025_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"FJ Neumann","year":"2020","unstructured":"Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407\u201377.","journal-title":"Eur Heart J"},{"key":"1025_CR2","unstructured":"National Center for Biotechnology Information. PubChem compound summary of ivabradine for CID 132999. 2022. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Ivabradine. Accessed 30 Nov 2022."},{"key":"1025_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.bjp.0705696","volume":"142","author":"X Du","year":"2004","unstructured":"Du X, Feng X, Gao X, Tan TP, Kiriazis H, Anthony M. If channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br J Pharmacol. 2004;142:107\u201312.","journal-title":"Br J Pharmacol"},{"key":"1025_CR4","first-page":"56","volume":"9","author":"BL Fala","year":"2016","unstructured":"Fala BL, Writer M. Corlanor (ivabradine), first HCN channel blocker, FDA approved for the treatment of patients with heart failure. Am Health Drug Benefits. 2016;9:56\u20139.","journal-title":"Am Health Drug Benefits"},{"key":"1025_CR5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","volume":"64","author":"D DiFrancesco","year":"2004","unstructured":"DiFrancesco D, Camm JA. Heart rate lowering by specific and selective If current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004;64:1757\u201365.","journal-title":"Drugs"},{"key":"1025_CR6","unstructured":"National Center for Biotechnology Information. PubChem compound summary of metoprolol for CID 4171. 2022. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Metoprolol. Accessed 30 Nov 2022."},{"key":"1025_CR7","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","volume":"22","author":"H Szwed","year":"2001","unstructured":"Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Szymczak K, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol. Eur Heart J. 2001;22:2267\u201374.","journal-title":"Eur Heart J"},{"key":"1025_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11094-018-1750-4","volume":"51","author":"TA Rodina","year":"2018","unstructured":"Rodina TA, Mel\u2019nikov ES, Dmitriev AI, Belkov SA, Sokolov AV, Arkhipov VV, et al. Simultaneous determination of metoprolol and bisoprolol in human serum by HPLC-MS\/MS for clinical drug monitoring. Pharm Chem J. 2018;51:1111\u20138.","journal-title":"Pharm Chem J."},{"key":"1025_CR9","unstructured":"Uses, interactions, mechanism of action of ivabradine drugbank. 2023. https:\/\/go.drugbank.com\/drugs\/DB09083. Accessed 20 Jan 2023."},{"key":"1025_CR10","unstructured":"Uses, interactions, mechanism of action of metoprolol drugbank. 2023. https:\/\/go.drugbank.com\/drugs\/DB00264. Accessed 20 Jan 2023."},{"key":"1025_CR11","first-page":"1475","volume":"9","author":"SL Kore","year":"2020","unstructured":"Kore SL, Kalyankar TM. Development and validation of UV-vis spectroscopy method for the determination of ivabradine hydrochloride and metoprolol succinate in tablet dosage form. J Pharm Educ Res. 2020;9:1475\u201382.","journal-title":"J Pharm Educ Res"},{"key":"1025_CR12","first-page":"1742","volume":"8","author":"S Bj","year":"2019","unstructured":"Bj S, Dg Y, Sm M, Da M. Developement and validation of stability indicating Rp-Hplc method for the estimation of metoprolol and ivabradine in solid dosage form. Bidkar World J Pharm Res. 2019;8:1742.","journal-title":"Bidkar World J Pharm Res"},{"key":"1025_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7324\/JAPS.2019.90418","volume":"9","author":"SB Kanthale","year":"2019","unstructured":"Kanthale SB, Thonte SS, Mahapatra DK. Stability indicating RP-HPLC method for the simultaneous estimation of ivabradine and metoprolol in bulk and tablet formulation. J Appl Pharm Sci. 2019;9:137\u201344.","journal-title":"J Appl Pharm Sci"},{"key":"1025_CR14","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1039\/C5AY01657F","volume":"7","author":"W Sun","year":"2015","unstructured":"Sun W, Chen R, Li W, Zhang H, Ye J, Cui X, et al. Simultaneous determination of ivabradine, metoprolol and their metabolites in rat plasma by ultra-performance liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study. Anal Methods. 2015;7:8459\u201365.","journal-title":"Anal Methods"},{"key":"1025_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-642-14025-9_2","volume-title":"High-performance thin-layer chromatography (HPTLC)","author":"PS Variyar","year":"2011","unstructured":"Variyar PS, Chatterjee SS. High-performance thin-layer chromatography (HPTLC). Heidelberg: Springer; 2011. p. 27\u201339."},{"key":"1025_CR16","first-page":"29","volume":"5","author":"B Ramu","year":"2018","unstructured":"Ramu B, Chittela KB. High performance thin layer chromatography and its role in the pharmaceutical industry: review. Sci J Biosci Bioeng. 2018;5:29\u201334.","journal-title":"Sci J Biosci Bioeng"},{"key":"1025_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jfda.2013.05.006","volume":"21","author":"P Pikul","year":"2013","unstructured":"Pikul P, Nowakowska J, Ciura K. Chromatographic analysis of ivabradine on polar, nonpolar and chemically modified adsorbents by HPTLC. J Food Drug Anal. 2013;21:165\u20138.","journal-title":"J Food Drug Anal"},{"key":"1025_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/10826076.2013.825844","volume":"37","author":"P Pikul","year":"2014","unstructured":"Pikul P, Nowakowska J, Ciura K. Effect of non-aqueous and buffered mobile-phase composition on the retention of ivabradine. J Liq Chromatogr Relat Technol. 2014;37:1837\u201346.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"1025_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/0973-1296.58565","volume":"5","author":"D Movalia","year":"2009","unstructured":"Movalia D, Mishra SH, Gajera F. Development and validation of HPTLC method for quantitative estimation of Oleanolic acid as marker in total methanolic extract of fruits of Randia dumetorum Lamk. Pharmacogn Mag. 2009;5:350\u20134.","journal-title":"Pharmacogn Mag"},{"key":"1025_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1556\/1326.2021.00890","volume":"34","author":"M Rizk","year":"2021","unstructured":"Rizk M, Toubar S, Ramzy E, Helmy M. Sensitive and validated TLC densitometry method coupled with fluorescence detection for quantitative determination of the newly co-formulated drugs, celecoxib and amlodipine besylate in tablet dosage form. Acta Chromatogr. 2021;34:150\u201361.","journal-title":"Acta Chromatogr"},{"key":"1025_CR21","unstructured":"ICH Validation of analytical procedures: text and methodology Q2(R1). In: International conference on harmonization. IFPMA, Geneva. 2005."},{"key":"1025_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical eco-scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TrAC Trends Anal Chem"},{"key":"1025_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: green analytical PROCEDURE INDEX. Talanta. 2018;181:204\u20139.","journal-title":"Talanta"},{"key":"1025_CR24","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014analytical GREEnness metric approach and software. Anal Chem. 2020;92:10076\u201382.","journal-title":"Anal Chem"},{"key":"1025_CR25","first-page":"141","volume":"6","author":"MC Damle","year":"2015","unstructured":"Damle MC, Bagwe RA. Development and validation of stability-indicating HPTLC method for ivabradine HCl. Pharma Sci Monit. 2015;6:141\u201352.","journal-title":"Pharma Sci Monit"},{"key":"1025_CR26","first-page":"233","volume":"51","author":"MH Motisariya","year":"2013","unstructured":"Motisariya MH, Patel KG, Shah PA. Validated stability-indicating high performance thin layer chromatographic method for determination of Ivabradine hydrochloride in bulk and marketed formulation\u202f: an application to kinetic study. Bull Fac Pharm Cairo Univ. 2013;51:233\u201341.","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"1025_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/0250-474X.103849","volume":"74","author":"PS Jain","year":"2012","unstructured":"Jain PS, Patel MK, Bari SB, Surana SJ. Development and validation of HPTLC method for simultaneous determination of amlodipine besylate and metoprolol succinate in bulk and tablets. Indian J Pharm Sci. 2012;74:152\u20136.","journal-title":"Indian J Pharm Sci"},{"key":"1025_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5530\/phm.2016.7.5","volume":"7","author":"D Desai","year":"2016","unstructured":"Desai D, Vashi N, Dalvadi H, Desai S, Hinge M. HPTLC method development and validation of cilnidipine and metoprolol succinate in combined dosage form. Pharm Methods. 2016;7:28\u201334.","journal-title":"Pharm Methods"},{"key":"1025_CR29","first-page":"115","volume":"22","author":"R Kakde","year":"2009","unstructured":"Kakde R, Bawane N. High-performance thin-layer chromatographic method for simultaneous analysis of metoprolol succinate and amlodipine besylate in pharmaceutical preparations. JPC. 2009;22:115\u20139.","journal-title":"JPC"},{"key":"1025_CR30","first-page":"217","volume":"4","author":"YS Bhangale","year":"2012","unstructured":"Bhangale YS, Gandhi SV, Deshpande PB, Potawale SE. A validated HPTLC method for simultaneous estimation of metoprolol succinate and Isosorbide mononitrate in combined capsule dosage form. Int J Pharm Pharm Sci. 2012;4:217\u201320.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1025_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1590\/S1984-82502013000400025","volume":"49","author":"AR Rote","year":"2013","unstructured":"Rote AR, Sonavane PR. Bioanalytical method development and validation for determination of metoprolol tartarate and hydrochlorothiazide using HPTLC in human plasma. Br J Pharm Sci. 2013;49:845\u201351.","journal-title":"Br J Pharm Sci"},{"key":"1025_CR32","volume-title":"Chemometrics for analytical chemistry","author":"JN Miller","year":"2005","unstructured":"Miller JN, Miller JC. Chemometrics for analytical chemistry. Hoboken: Wiley; 2005."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-023-01025-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:31:21Z","timestamp":1700404281000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-023-01025-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1186\/s13065-023-01025-x","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"Declare no competing of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}